The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tesco PLC
LSE:TSCO
|
UK |
|
CryptoStar Corp
XTSX:CSTR
|
CA |
|
G
|
GN Store Nord A/S
F:GNN
|
DK |
|
N
|
Nanjing Panda Electronics Co Ltd
SSE:600775
|
CN |
|
CH Robinson Worldwide Inc
NASDAQ:CHRW
|
US |
|
H
|
Helmerich and Payne Inc
SWB:HPC
|
US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
US |
|
SPX Corp
NYSE:SPXC
|
US |
|
M
|
Markel Corp
F:MKV
|
US |
|
Cordoba Minerals Corp
XTSX:CDB
|
CA |
|
I
|
Ibiden Co Ltd
OTC:IBIDF
|
JP |
|
Cushman & Wakefield Ltd
NYSE:CWK
|
BM |
|
M
|
Manyo Factory Co Ltd
KOSDAQ:439090
|
KR |
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
IL |
|
Q
|
QD Laser Inc
TSE:6613
|
JP |
|
Hardide PLC
LSE:HDD
|
UK |
|
Innovatec SpA
MIL:INC
|
IT |
|
Livero Inc
TSE:9245
|
JP |
|
Bourse Direct SA
F:BD6
|
FR |
|
Nippon Shindo Co Ltd
TSE:5753
|
JP |
|
S
|
SSE PLC
F:SCT
|
UK |
|
C
|
CVS Health Corp
DUS:CVS
|
US |
|
N
|
Nissin Foods Holdings Co Ltd
SWB:NF2
|
JP |
|
Ley Choon Group Holdings Ltd
SGX:Q0X
|
SG |
Tesco PLC (TSCO)’s 12-month stock price forecast through September 2027 has a consensus target of 525.3 GBX, implying 12% upside. The forecast is based on price targets from 17 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
TSCO is 525.3 GBX with a low forecast of 464.6 GBX and a high forecast of 577.5 GBX.
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 5 years is 3%.
Over the last 14 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 5 years is 2%.
Over the last 14 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 6 years is 2%.
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 8%.
Over the last 14 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 7%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more